Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Post-Marketing Surveillance of CAROGRA Tablets in Ulcerative Colitis
jRCT2031220193Recruiting
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of firategrast in autoimmune colitis, sponsored by EA Pharma Co., Ltd. Primary endpoint: Partial Mayo Score. Started Jun 2022; status: recruiting.
02
Drugs
firategrast
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2031220193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220193.